SCHEMBL529645

SCHEMBL529645

Cc1ncccc1-c1ccc(N)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
KDM4E B2RXH2 2/20 0.50
MAPT P10636 2/20 0.50
NPC1 O15118 1/20 0.50
GAA P10253 1/20 0.50
RAB9A P51151 1/20 0.50
PLA2G7 Q13093 1/20 0.47
CYP3A4 P08684 3/20 0.44
MAP4K4 O95819 1/20 0.40
TSHR P16473 2/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
TP53 P04637 1/20 0.40
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
CASP1 P29466 1/20 0.40
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15730116 0.83 L3MBTL1 (0.52) ALDH1A1MAPTNPC1RAB9AL3MBTL1
SCHEMBL24391135 0.81 PDE3B (0.46) ALDH1A1SMN1; SMN2KDM4EMAPTMAP4K4
SCHEMBL5685338 0.81 NPC1 (0.49) ALDH1A1SMN1; SMN2KDM4EMAPTNPC1
SCHEMBL7089197 0.79 MAP4K4 (0.42) ALDH1A1SMN1; SMN2KDM4EMAPTNPC1
SCHEMBL15731251 0.78 PDE2A (0.48) ALDH1A1SMN1; SMN2NPC1RAB9APLA2G7
SCHEMBL20595575 0.78 HSP90AA1 (0.44) RAB9ACYP3A4TSHRHSP90AA1HSP90AB1
SCHEMBL31501737 0.77 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2KDM4EMAPTNPC1
SCHEMBL19814079 0.77 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2KDM4EMAPTNPC1
SCHEMBL302092 0.75 CYP3A4 (0.65) ALDH1A1SMN1; SMN2KDM4EMAPTNPC1
SCHEMBL3421959 0.75 MKNK1 (0.52) SMN1; SMN2KDM4EMAPTNPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598481-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS Bristol-Myers Squibb Company (US) 2013-06-05 EP disclosed
WO-2012015723-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-02 WO disclosed